Multiple-type meningitis pathogen nucleic acid IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Multiple-type meningitis pathogen nucleic acid IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 113571. The device is manufactured by Fast Track Diagnostics Luxembourg SARL from Luxembourg, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Siemens Healthcare Diagnostics Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

Multiple-type meningitis pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)

MHRA Device ID: 113571•Ref: 113571

Device Type

In Vitro Diagnostic Device

Devices

Multiple-type meningitis pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Oct 9, 2024

Manufacturer Information

Name

Fast Track Diagnostics Luxembourg SARL

Address

29, rue Henri Koch, Esch-sur-Alzette

Luxembourg, Luxembourg

Created Date

Nov 17, 2021

Authorized Representative

Name

Siemens Healthcare Diagnostics Limited

Relationship Type

UK Responsible Person

Address

Park View Watchmoor Park

Surrey, Camberley, England, United Kingdom

Postcode: GU15 3YL

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from Fast Track Diagnostics Luxembourg SARL (2)

Multiple-type respiratory pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)

Type: In Vitro Diagnostic Device

Registered: Nov 26, 2024

SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)

Type: In Vitro Diagnostic Device

Registered: Nov 26, 2024

Other Products from Same Authorized Representative (10)

Multiple-type meningitis pathogen nucleic acid IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Device Type

Devices

Type

Date Registered

Last Updated

Name

Address

Created Date

Name

Relationship Type

Address

DJ Fang

Alpha-fetoprotein (AFP) IVD, kit, fluorescent immunoassay

Cyclic citrullinated peptide antibody (anti-CCP) IVD, kit, fluorescent immunoassay

Streptococcus pneumoniae antigen IVD, kit, rapid ICT, clinical

Allergen-specific/total immunoglobulin E (IgE) antibody IVD, kit, fluorescent immunoassay

C-reactive protein (CRP) IVD, kit, fluorescent immunoassay

Cryptosporidium species antigen IVD, kit, rapid ICT, clinical

Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

Trichomonas vaginalis antigen IVD, kit, rapid ICT, clinical

D-dimer IVD, kit, fluorescent immunoassay

Multiple-type respiratory pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)

SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)

Salicylate IVD, calibrator

Salicylate IVD, kit, enzyme immunoassay (EIA)

Salicylate IVD, kit, spectrophotometry

Specimen processing instrument IVD

Tacrolimus therapeutic drug monitoring IVD, calibrator

Theophylline therapeutic drug monitoring IVD, calibrator

Theophylline therapeutic drug monitoring IVD, kit, enzyme immunoassay (EIA)

Theophylline therapeutic drug monitoring IVD, kit, nephelometry/turbidimetry

Thyroid stimulating hormone (TSH) IVD, kit, chemiluminescent immunoassay

Cyclosporin A/cyclosporine therapeutic drug monitoring IVD, control